UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                               Amendment No. 1 to

                                   FORM 8-K/A

                                 Current Report

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



                                December 27, 2002
                                -----------------
                      (Date of the earliest event reported)



                                PhotoMedex, Inc.
                                ---------------
             (Exact name of Registrant as specified in its charter)


          Delaware                     0-11635             59-2858100
          --------                     -------             ----------
(State or other jurisdiction  (Commission File Number)  (I.R.S. Employer
        of incorporation)                              Identification No.)

       Five Radnor Corporate Center, Suite 470, Radnor, Pennsylvania 19087
       -------------------------------------------------------------------
               (Address of principal executive offices)          (Zip Code)

                                  610-971-9292
                                  ------------
               Registrant's telephone number, including area code


Item 2.           Acquisition or Disposition of Assets.

     On December 27, 2002,  PhotoMedex,  Inc.  ("PhotoMedex") and Surgical Laser
Technologies,   Inc.   ("SLT")   completed  the  previously   announced   merger
contemplated  by the Agreement  and Plan of Merger dated  September 25, 2002, by
and among PhotoMedex, SLT and J Merger Corp., Inc., a wholly owned subsidiary of
PhotoMedex  ("Merger Sub"). As contemplated by the merger agreement,  Merger Sub
merged with and into SLT, with SLT as the surviving  corporation  and becoming a
wholly owned  subsidiary of  PhotoMedex.  The holders of SLT common stock issued
and  outstanding  immediately  prior to the effective time of the merger,  other
than any shares as to which appraisal rights had been duly perfected pursuant to
Delaware law and not effectively withdrawn or lost prior to or subsequent to the
effective  time, are entitled to receive 1.12 shares of newly issued  PhotoMedex
common stock in exchange for each share of SLT common stock they held, with cash
to be paid in lieu of any  fractional  shares at a rate of  $1.826  per share of
PhotoMedex  common  stock,  the average  closing  price of a share of PhotoMedex
common stock on the Nasdaq National Market for the twenty trading days ending on
December 26, 2002. As a result of the merger,  PhotoMedex  will issue a total of
approximately  2.7 million  shares of its common  stock and will assume  certain
outstanding common stock purchase warrants of SLT.

     Richard  DePiano,  who served as SLT's Chairman of the Board and a director
prior to the merger, also served as a director of PhotoMedex prior to the merger
and will  continue  to so serve  following  the  merger.  In  addition,  Michael
Stewart,  the President and Chief Executive  Officer and a director of SLT prior
to the  merger,  and Davis  Woodward,  SLT's Vice  President,  Finance and Chief
Financial Officer prior to the merger,  have entered into employment  agreements
with PhotoMedex to serve as its Executive Vice President of Corporate Operations
and in-house General Counsel, respectively.

     For further  information  regarding the terms and  conditions of the merger
and the merger  agreement,  reference is made to the merger  agreement  filed as
Exhibit 2.1 hereto and incorporated by reference herein.

                                       2



Item 7. Financial Statements and Exhibits.


     (a)  The financial  statements  required by Rule 3-05(b) of Regulation  S-X
          are included as Exhibit 99.1 hereto.

     (b)  The  pro  forma  financial  information  required  by  Article  11  of
          Regulation S-X are included as Exhibit 99.2
hereto.

     (c)  Exhibits:

          2.1  Agreement  and Plan of Merger  dated  September  25,  2002 by and
               among   Registrant,   PhotoMedex,   Inc.  and  J  Merger   Corp.,
               incorporated   by   reference   to   Annex   A   of   the   Proxy
               Statement/Prospectus   included  in  the  Form  S-4  Registration
               Statement,  Commission File No. 333-100609,  filed by PhotoMedex,
               Inc. on October 18, 2002.(1)

          99.1 Financial Statements of Surgical Laser Technologies, Inc.

          99.2 Pro Forma Financial Information of PhotoMedex,  Inc. and Surgical
               Laser Technologies, Inc.

__________________________

(1)  Previously  incorporated  by reference and filed as an exhibit to this Form
     8-K.


                                       3


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                           PHOTOMEDEX, INC.



Dated:  February 13, 2003         By: /s/ Dennis M. McGrath
                                      -------------------------
                                      Dennis M. McGrath
                                      Chief Financial Officer




                                       4


                            EXHIBIT INDEX
                            -------------

Exhibit Number                Description
- --------------                -----------
2.1  Agreement and Plan of Merger by and among PhotoMedex,  Inc., Surgical Laser
     Technologies,   Inc.  and  J  Merger  Corp.   dated   September  25,  2002,
     incorporated  by  reference  to Annex A of the  Proxy  Statement/Prospectus
     included  in the  Form  S-4  Registration  Statement,  Commission  File No.
     333-100609, filed by PhotoMedex, Inc. on October 18, 2002.

99.1 Financial Statements of Surgical Laser Technologies, Inc.

99.2 Pro Forma  Financial  Information  of  PhotoMedex,  Inc. and Surgical Laser
     Technologies, Inc.






                                       5